Jefferies analyst Farzin Haque lowered the price target on Pyxis Oncology Inc. (NASDAQ: PYXS) to $6.00 (from $12.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE